Skip to search formSkip to main contentSkip to account menu

formoterol

Known as: Formoterol [Chemical/Ingredient], Eformoterol, 2'-Hydroxy-5'-(1-hydroxy-2-((P-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide 
A long-acting beta-adrenergic receptor agonist with bronchodilator activity. Formoterol selectively binds to beta-2 adrenergic receptors in bronchial… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Background: Two-stage (S1, S2) adaptive design study to compare systemic BA and PD of FP and FORM via the BTI (Flutiform® K-haler… 
2017
2017
Background: This study aimed to show that pulmonary BA of FP and FORM via the BTI (Flutiform® K‑haler®) was no less than via pMDI… 
2010
2010
Pharmacoeconomic assessment of combine therapy of bronchial asthma by inhaled corticostero-ids (ICS) budesonide and long-acting… 
Review
2003
Review
2003
Despite concerns in the 1970s and 1980s about the safety of short-acting beta2-agonists, it is now generally accepted that these… 
2001
2001
Dos nuevos beta agonistas de efecto prolongado son actualmente usados clinicamente: salmeterol y formoterol. El primero no ha… 
1999
1985
1985
The authors administered orally 40, 60 and 80 micrograms of Formoterol which was developed as a new bronchodilator and 4 mg of… 
1984
1984
Formoterol was evaluated for its inhibitory effects on tissue tonus of the isolated guinea-pig lung parenchymal (peripheral… 
1981
1981
The effects of formoterol (BD 40A) on the rat and guinea-pig hypersensitivity reactions and on mouse IgE antibody formation was…